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Abstract
Apixaban is a direct oral anticoagulant that works by inhibiting factor Xa. It has been associated with adverse bleeding
outcomes including atraumatic splenic rupture. We present the case of an 86-year-old man who presented with features of
left upper abdominal pain and hemorrhagic shock found to have atraumatic splenic rupture and hemoperitoneum on imaging.
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Introduction
Apixaban is a direct oral anticoagulant (DOAC) approved by
the US Food and Drug Administration (FDA) for use in nonvalvular atrial fibrillation for stroke prevention.1 DOACs are
associated with an increased risk of bleeding. Recently,
atraumatic splenic rupture has been reported with their
increasing use.2–8 We present a case of a spontaneous splenic
rupture with hemorrhagic shock requiring emergent splenic
artery embolization and splenectomy in the setting of apixaban use.

Case description
An 86-year-old gentleman presented to the emergency
department (ED) after a fall due to orthostatic syncope. He
had complained of left upper quadrant abdominal pain the
night prior. According to his wife, he was restless overnight
and had gone to the bathroom that morning when she heard
him fall. The patient denied trauma prior to the onset of
abdominal pain, recent sore throat, fever, chills, night sweats,
weight loss, fatigue, reflux, or recent travel. His history was
significant for atrial fibrillation, coronary artery disease,
hypertension, hyperlipidemia, and type II diabetes mellitus.
He did not have a history of bleeding or clotting disorders.
His home medications included apixaban 5 mg two times
daily, aspirin 81 mg daily, atorvastatin 40 mg daily, carvedilol 12.5 mg two times daily, hydrochlorothiazide 25 mg
daily, lisinopril 10 mg daily, and metformin 500 mg two
times daily. He was not on any medications with CYP3A4 or

P-gp-inhibiting activity. On presentation, his temperature
was 36.7°C (98.1°F), blood pressure was 107/67 mm Hg
with nadir of 74/46 mm Hg, heart rate was 65/min, and respiratory rate was 16 breaths per minute. Physical examination was significant for diffuse bilateral abdominal tenderness
without any guarding or rebound tenderness. He was lethargic and slow to follow commands. The remainder of the
physical examination was normal.
Serologic testing revealed his hemoglobin was 11.8 g/dL
(reference range: 14.0–17.5 g/dL), down from a baseline of
14 g/dL. Coagulation panel revealed international normalized
ratio (INR) of 1.2 (reference range: 0.9–1.1), prothrombin time
(PT) of 14.9 s (reference range: 11.7–14.1 s), activated partial
thromboplastin time (aPTT) of 28 s (reference range: 23–34 s),
and platelets 146,000/µL (reference range: 130,000–400,000/µL).
His random blood sugar was 268 mg/dL (reference range: 70–
99 mg/dL). Computed tomography (CT) of the abdomen/pelvis
with contrast showed active extravasation from the spleen with
a large subcapsular hematoma and hemoperitoneum (Figure
1). CT head with cervical spine was negative for acute intracranial mass or hemorrhage, fracture, or focal bony lesions. He
was given 2.5 L of normal saline to maintain his systolic blood
pressure over 100 mg Hg. He received a unit of prothrombin
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Figure 1. CT scan of the abdomen/pelvis showing large
subcapsular hematoma and active extravasation from the spleen
with associated hemoperitoneum.

complex concentrate (PCC), 2 units of packed red blood cells
(PRBCs), and 2 units of fresh frozen plasma (FFP) in the ED to
reverse his coagulopathy. The patient was taken for emergent
splenic arteriography and embolization. Embolization was initially pursued to avoid the need for an exploratory laparotomy
as his blood pressures stabilized with initial volume resuscitation. Images after contrast injection demonstrated a small area
of extravasation from the inferior tip of the spleen in the area of
the abnormality seen on CT scan. The proximal third of the
splenic artery was successfully embolized with a 10-mm
Amplatzer 2 plug device. Post procedure, the patient’s blood
pressure improved to 154/47 mm Hg. He was then admitted to
the surgical intensive care unit for close monitoring. Over the
course of hours, the patient again deteriorated and was hypotensive with systolic blood pressure in the 80s. He was short of
breath. Bedside focused assessment with sonography for
trauma (FAST) scan showed a flat inferior vena cava and a
large hemoperitoneum. With concern for ongoing bleed, the
patient was transfused 2 units of PRBCs and was taken to the
operating room for exploratory laparotomy and splenectomy
for a ruptured subcapsular splenic hematoma. Around 1500 mL
of bloody fluid was removed from the peritoneum. No retroperitoneal hematoma was noted. Splenic pathology revealed
capsular disruption with associated subcapsular and intraparenchymal hemorrhage, and numerous macrophages within
the splenic parenchyma likely secondary to a reactive phenomenon. His hematoma was thought to be related to apixaban use
in the absence of trauma or splenic pathology. Patient’s postoperative hospital stay was unremarkable. His hemoglobin was
stable at 11.7 g/dL. He was discharged on day 5 with recommendations to resume apixaban and aspirin.

Discussion
Spontaneous splenic rupture is a rare entity but has been
noted to occur with infections such as infectious mononucleosis; hematologic neoplasms such as leukemia and
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lymphoma; non-infectious, inflammatory disorders such as
amyloidosis and polyarteritis nodosa; medications; dialysis;
and pregnancy.9,10 Orloff and Peskin11 established four criteria for spontaneous rupture of the normal spleen to which a
fifth criterion was later added by Crate and Payne.12 In our
case, the biopsy was negative for infiltrating atypical lymphocytes or monocytes that would be suggestive of infection, neoplasm, or inflammatory disorders. His renal function
was unremarkable. Although he had a fall, this was preceded
by left upper quadrant pain. Thus, we believe that his orthostatic syncope was a manifestation of low intravascular volume status from preceding splenic hemorrhage. We were not
able to find an etiology for splenic rupture other than apixaban use.
DOACs, apixaban, rivaroxaban, and dabigatran have all
been associated with atraumatic splenic rupture in previous
literature.2–8 This is the third case related to apixaban.7,8
Apixaban has anticoagulant properties by inhibiting free and
bound form of factor Xa.1 Lowry and Goldner7 suggest that
apixaban may worsen previously undetected microtrauma
that may lead to splenic hemorrhage. Concomitant use of
antiplatelets, p-glycoprotein, and CYP3A4-inhibiting medications and poor renal function all increase the risk of bleeding with DOACs.2 Our patient was not on any medications
that were associated with p-glycoprotein and CYP3A4inhibiting activity. Atraumatic splenic rupture was noted
early after initiation of a DOAC. Splenic rupture was
reported 1 day, 2 days, and 2 months after initiation of dabigatran,6 apixaban,8 and rivaroxaban,4 respectively. Leftsided abdominal pain that may radiate to the shoulder,
declining hemoglobin levels, hypotension, and features of
hemorrhagic shock all suggest splenic hemorrhage.6,7 Due to
its non-specific clinical picture, it can easily be mistaken for
peptic ulcer disease or cardiac disease in the absence of
trauma. Diagnosis should especially be considered in a
patient who is on anticoagulation.7
Besides ultrasound can be urgently performed in these
patients for rapid diagnosis,8 it can detect free fluid with 90%
sensitivity and 99% specificity13 and can aid in early diagnosis and urgent consultations and guide treatment plans in
cases with undifferentiated hypotension.14 CT scan is a recommended imaging modality for diagnosis, staging, and
decision on surgical management.8 Initial management
includes discontinuation of anticoagulants, volume resuscitation, and, if available, reversal of anticoagulation. Volume
resuscitation with intravenous isotonic crystalloids offers the
same benefit as colloids.15 PCC, FFP, and recombinant activated factor VII can be used in this setting despite lack of
evidence.3 Current guidelines recommend RBC transfusion,
platelet, and cryoprecipitate transfusion to maintain target
hemoglobin >7 g/dL, platelet count >50,000/µL, and fibrinogen >100 mg/dL, respectively.15 With andexanet alfa being
approved by FDA for reversal of anticoagulation in lifethreatening or uncontrolled bleeding,16 it will be interesting
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to know its efficacy in patients with splenic hemorrhage.
Surgical options for splenic rupture include conservative
transcatheter arterial embolization and open surgical exploration.9 Spontaneous splenic hemorrhage can be managed
conservatively with close monitoring if the patient is hemodynamically stable without signs of active hemorrhage or
peritonitis.6,7 Embolization can be tried in hemodynamically
stable patients with active contrast extravasation noted in CT
angiography.17 Emergent laparotomy with splenectomy
should be performed in hemodynamically unstable patients.7

Conclusion
Atraumatic splenic hemorrhage is life-threatening, and high
index of suspicion for this should be maintained in patients
presenting with abdominal pain, features of hypotension,
and hemorrhagic shock while on apixaban. We hope this
case will bring forward more similar reports in the future.
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